Table 2 Laboratory findings of patients with BSCL
From: Clinical and laboratory data of a large series of patients with congenital generalized lipodystrophy
Test | Result | Reference range |
|---|---|---|
Glycemia (mg/dl) | 89 (55–424) | 70–99 |
Non diabetic | 71 (55–86) | |
Diabetic | 152 (67–424) | |
Glycated hemoglobin (%) | 7.4 ± 2.1 | <5.7 |
Non diabetic | 5.4 ± 0.7 | |
Diabetic | 8.3 ± 1.9 | |
Total cholesterol (mg/dl) | 170 (106–316) | <200 |
HDL cholesterol (mg/dl) | 30.3 (18–44) | >40 (>50) |
LDL cholesterol (mg/dl) | 98.6 ± 40.6 | – |
Non HDL cholesterol (mg/dl) | 147.9 ± 43 | – |
Triglyceridemia (mg/dl) | 276 (119–1121) | <150 |
Non diabetic | 190.5 (124–422) | |
Diabetic | 330 (119–1121) | |
Urea (mg/dl) | 26 (10–74) | 15–45 |
Creatinine (mg/dl) | 0.5 (0.3–1.4) | 0.6–1.2 |
AST (mg/dl) | 31 (13–98) | <40 |
ALT (mg/dl) | 35 (10–210) | <40 |
GGT (mg/dl) | 31.5 (11–552) | |
Women | 35 (11–552) | <38 |
Men | 24 (14–114) | <55 |
Insulin (mUI/ml) | 25.8 (2.0–164.0) | <16 |
Patients <10 years | 11.0 (2.0–41.0) | |
Patients >10 years | 27.8 (4.9–164.0) | |
HOMAIR | 7.3 (0.3–73.8) | <2.7 |
Leptin (ng/ml) | 1.0 (0.4–2.3) | |
Women | 1.0 (0.4–2.3) | <14.7 |
Men | 0.9 (0.5–1.7) | <7.4 |